USANA HEALTH SCIENCES, INC. Stock-Based Compensation
USANA HEALTH SCIENCES, INC. (USNA) reported Stock-Based Compensation of $6.86 million for the 6-month period ending 2026-07-04, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-07-04 was $3.40M, a 6.02% decline year-over-year.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-04-04 was $3.45M, a 19.93% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-01-03 was $3.75M, a 3.79% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-27 was $3.58M, a 0.96% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2026 was $13.83M, a 5.01% decline from fiscal 2024.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $14.56M, a 0.25% decline from fiscal 2023.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $14.60M, a 9.48% increase from fiscal 2022.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $13.33M, a 6.76% decline from fiscal 2022.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-07-04 | $3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $6.86M 10-Q · filed 2026-08-13 | $10.61M derived: sum of 3 quarters · filed 2026-08-13 | $14.18M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-04-04 | $3.45M 10-Q · filed 2026-05-12 | $7.20M derived: sum of 2 quarters · filed 2026-05-12 | $10.78M derived: sum of 3 quarters · filed 2026-05-12 | $14.40M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-01-03 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $7.33M derived: sum of 2 quarters · filed 2026-03-16 | $10.95M derived: sum of 3 quarters · filed 2026-08-13 | $13.83M 10-K · filed 2026-03-16 |
| 2025-09-27 | $3.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.20M derived: sum of 2 quarters · filed 2026-08-13 | $10.08M 10-Q · filed 2025-11-05 | $13.69M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-28 | $3.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $6.50M 10-Q · filed 2026-08-13 | $10.12M derived: sum of 3 quarters · filed 2026-08-13 | $13.66M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-29 | $2.88M 10-Q · filed 2026-05-12 | $6.49M derived: sum of 2 quarters · filed 2026-05-12 | $10.04M derived: sum of 3 quarters · filed 2026-05-12 | $13.77M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-28 | $3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $7.16M derived: sum of 2 quarters · filed 2026-03-16 | $10.89M derived: sum of 3 quarters · filed 2026-03-16 | $14.56M 10-K · filed 2026-03-16 |
| 2024-09-28 | $3.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.28M derived: sum of 2 quarters · filed 2025-11-05 | $10.95M 10-Q · filed 2025-11-05 | $14.59M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-29 | $3.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $7.40M 10-Q · filed 2025-08-05 | $11.05M derived: sum of 3 quarters · filed 2026-03-16 | $14.72M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-30 | $3.67M 10-Q · filed 2025-05-06 | $7.31M derived: sum of 2 quarters · filed 2026-03-16 | $10.98M derived: sum of 3 quarters · filed 2026-03-16 | $14.66M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-30 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $7.31M derived: sum of 2 quarters · filed 2026-03-16 | $10.99M derived: sum of 3 quarters · filed 2026-03-16 | $14.60M 10-K · filed 2026-03-16 |
| 2023-09-30 | $3.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $7.34M derived: sum of 2 quarters · filed 2024-11-05 | $10.95M 10-Q · filed 2024-11-05 | $14.47M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-07-01 | $3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $7.28M 10-Q · filed 2024-08-06 | $10.80M derived: sum of 3 quarters · filed 2025-03-12 | $13.87M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-04-01 | $3.61M 10-Q · filed 2024-05-07 | $7.12M derived: sum of 2 quarters · filed 2025-03-12 | $10.20M derived: sum of 3 quarters · filed 2025-03-12 | $13.76M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $6.59M derived: sum of 2 quarters · filed 2025-03-12 | $10.15M derived: sum of 3 quarters · filed 2025-03-12 | $13.33M 10-K · filed 2025-03-12 |
| 2022-10-01 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $6.63M derived: sum of 2 quarters · filed 2023-11-07 | $9.81M 10-Q · filed 2023-11-07 | $13.07M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-02 | $3.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $6.74M 10-Q · filed 2023-08-08 | $10.00M derived: sum of 3 quarters · filed 2024-02-27 | $13.45M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-02 | $3.18M 10-Q · filed 2023-05-09 | $6.44M derived: sum of 2 quarters · filed 2024-02-27 | $9.90M derived: sum of 3 quarters · filed 2024-02-27 | $13.74M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-01-01 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $6.71M derived: sum of 2 quarters · filed 2024-02-27 | $10.56M derived: sum of 3 quarters · filed 2024-02-27 | $14.30M 10-K · filed 2024-02-27 |
| 2021-10-02 | $3.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $7.30M derived: sum of 2 quarters · filed 2022-11-08 | $11.04M 10-Q · filed 2022-11-08 | $14.91M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-07-03 | $3.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $7.58M 10-Q · filed 2022-08-09 | $11.46M derived: sum of 3 quarters · filed 2023-02-28 | $14.99M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-04-03 | $3.74M 10-Q · filed 2022-05-11 | $7.62M derived: sum of 2 quarters · filed 2023-02-28 | $11.14M derived: sum of 3 quarters · filed 2023-02-28 | $14.74M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-01-02 | $3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $7.40M derived: sum of 2 quarters · filed 2023-02-28 | $11.00M derived: sum of 3 quarters · filed 2023-02-28 | $14.39M 10-K · filed 2023-02-28 |
| 2020-09-26 | $3.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $7.13M derived: sum of 2 quarters · filed 2021-11-10 | $10.52M 10-Q · filed 2021-11-10 | $13.38M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-27 | $3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $6.99M 10-Q · filed 2021-08-11 | $9.85M derived: sum of 3 quarters · filed 2022-03-01 | $13.93M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-28 | $3.39M 10-Q · filed 2021-05-11 | $6.25M derived: sum of 2 quarters · filed 2022-03-01 | $10.33M derived: sum of 3 quarters · filed 2022-03-01 | $15.10M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-28 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.94M derived: sum of 2 quarters · filed 2022-03-01 | $11.71M derived: sum of 3 quarters · filed 2022-03-01 | $15.54M 10-K · filed 2022-03-01 |
| 2019-09-28 | $4.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $8.85M derived: sum of 2 quarters · filed 2020-11-03 | $12.68M 10-Q · filed 2020-11-03 | $16.61M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-29 | $4.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $8.60M 10-Q · filed 2020-08-04 | $12.53M derived: sum of 3 quarters · filed 2021-03-02 | $16.50M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-30 | $3.83M 10-Q · filed 2020-05-05 | $7.76M derived: sum of 2 quarters · filed 2021-03-02 | $11.73M derived: sum of 3 quarters · filed 2021-03-02 | $14.98M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-29 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $7.90M derived: sum of 2 quarters · filed 2021-03-02 | $11.15M derived: sum of 3 quarters · filed 2021-03-02 | $14.96M 10-K · filed 2021-03-02 |
| 2018-09-29 | $3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $7.22M derived: sum of 2 quarters · filed 2019-11-05 | $11.03M 10-Q · filed 2019-11-05 | $14.80M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $3.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $7.06M 10-Q · filed 2019-08-06 | $10.83M derived: sum of 3 quarters · filed 2020-02-25 | $14.54M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $3.81M 10-Q · filed 2019-05-07 | $7.58M derived: sum of 2 quarters · filed 2020-02-25 | $11.29M derived: sum of 3 quarters · filed 2020-02-25 | $15.09M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-30 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $7.48M derived: sum of 2 quarters · filed 2020-02-25 | $11.28M derived: sum of 3 quarters · filed 2020-02-25 | $15.48M 10-K · filed 2020-02-25 |
| 2017-09-30 | $3.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $7.51M derived: sum of 2 quarters · filed 2018-11-07 | $11.71M 10-Q · filed 2018-11-07 | $14.29M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-07-01 | $3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $8.00M 10-Q · filed 2018-08-08 | $10.58M derived: sum of 3 quarters · filed 2019-02-26 | $15.12M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-04-01 | $4.20M 10-Q · filed 2018-05-09 | $6.78M derived: sum of 2 quarters · filed 2019-02-26 | $11.32M derived: sum of 3 quarters · filed 2019-02-26 | $16.13M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $7.12M derived: sum of 2 quarters · filed 2019-02-26 | $11.93M derived: sum of 3 quarters · filed 2019-02-26 | $16.54M 10-K · filed 2019-02-26 |
| 2016-10-01 | $4.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $9.35M derived: sum of 2 quarters · filed 2017-11-08 | $13.96M 10-Q · filed 2017-11-08 | $18.09M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-07-02 | $4.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $9.42M 10-Q · filed 2017-08-09 | $13.55M derived: sum of 3 quarters · filed 2018-02-28 | $16.11M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-04-02 | $4.61M 10-Q · filed 2017-05-10 | $8.74M derived: sum of 2 quarters · filed 2018-02-28 | $11.30M derived: sum of 3 quarters · filed 2018-02-28 | $13.48M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-01-02 | $4.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $6.69M derived: sum of 2 quarters · filed 2018-02-28 | $8.87M derived: sum of 3 quarters · filed 2018-02-28 | $11.08M 10-K · filed 2018-02-28 |
| 2015-10-03 | $2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $4.74M derived: sum of 2 quarters · filed 2016-11-09 | $6.95M 10-Q · filed 2016-11-09 | $10.83M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-07-04 | $2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.39M 10-Q · filed 2016-08-09 | $8.26M derived: sum of 3 quarters · filed 2017-03-01 | $10.12M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-04-04 | $2.21M 10-Q · filed 2016-05-11 | $6.09M derived: sum of 2 quarters · filed 2017-03-01 | $7.94M derived: sum of 3 quarters · filed 2017-03-01 | $10.18M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-01-03 | $3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $5.73M derived: sum of 2 quarters · filed 2017-03-01 | $7.97M derived: sum of 3 quarters · filed 2017-03-01 | $9.80M 10-K · filed 2017-03-01 |
| 2014-09-27 | $1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $4.09M derived: sum of 2 quarters · filed 2015-11-12 | $5.93M 10-Q · filed 2015-11-12 | $7.44M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-06-28 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $4.07M 10-Q · filed 2015-08-12 | $5.58M derived: sum of 3 quarters · filed 2016-03-01 | $7.27M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-03-29 | $1.84M 10-Q · filed 2015-05-13 | $3.35M derived: sum of 2 quarters · filed 2016-03-01 | $5.03M derived: sum of 3 quarters · filed 2016-03-01 | $7.09M derived: sum of 4 quarters · filed 2016-03-01 |
| 2013-12-28 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $3.20M derived: sum of 2 quarters · filed 2016-03-01 | $5.25M derived: sum of 3 quarters · filed 2016-03-01 | $7.62M 10-K · filed 2016-03-01 |
| 2013-09-28 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $3.74M derived: sum of 2 quarters · filed 2014-11-06 | $6.11M 10-Q · filed 2014-11-06 | $8.14M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-06-29 | $2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $4.43M 10-Q · filed 2014-08-05 | $6.45M derived: sum of 3 quarters · filed 2015-03-17 | $9.02M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-03-30 | $2.37M 10-Q · filed 2014-05-07 | $4.39M derived: sum of 2 quarters · filed 2015-03-17 | $6.96M derived: sum of 3 quarters · filed 2015-03-17 | $9.71M derived: sum of 4 quarters · filed 2015-03-17 |
| 2012-12-29 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | $4.59M derived: sum of 2 quarters · filed 2015-03-17 | $7.34M derived: sum of 3 quarters · filed 2015-03-17 | $10.21M 10-K · filed 2015-03-17 |
| 2012-09-29 | $2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $5.32M derived: sum of 2 quarters · filed 2013-11-07 | $8.18M 10-Q · filed 2013-11-07 | $10.99M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $5.62M 10-Q · filed 2013-08-08 | $8.43M derived: sum of 3 quarters · filed 2014-03-13 | $11.37M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | $2.87M 10-Q · filed 2013-05-07 | $5.68M derived: sum of 2 quarters · filed 2014-03-13 | $8.61M derived: sum of 3 quarters · filed 2014-03-13 | $10.18M derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $5.75M derived: sum of 2 quarters · filed 2014-03-13 | $7.31M derived: sum of 3 quarters · filed 2014-03-13 | $10.55M 10-K · filed 2014-03-13 |
| 2011-10-01 | $2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $4.50M derived: sum of 2 quarters · filed 2012-11-07 | $7.74M 10-Q · filed 2012-11-07 | $11.04M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-07-02 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $4.80M 10-Q · filed 2012-08-08 | $8.10M derived: sum of 3 quarters · filed 2013-03-11 | $11.07M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-04-02 | $3.23M 10-Q · filed 2012-05-10 | $6.53M derived: sum of 2 quarters · filed 2013-03-11 | $9.50M derived: sum of 3 quarters · filed 2013-03-11 | |
| 2011-01-01 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $6.27M derived: sum of 2 quarters · filed 2013-03-11 | $10.41M 10-K · filed 2013-03-11 | |
| 2010-10-02 | $2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $7.11M 10-Q · filed 2011-11-09 | ||
| 2010-07-03 | $4.14M 10-Q · filed 2011-08-10 | |||
| 2010-01-02 | $8.93M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |